Insider Selling: Aveanna Healthcare (NASDAQ:AVAH) CFO Sells 13,512 Shares of Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) CFO Matthew Buckhalter sold 13,512 shares of the business’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $7.21, for a total transaction of $97,421.52. Following the transaction, the chief financial officer owned 529,243 shares in the company, valued at approximately $3,815,842.03. This trade represents a 2.49% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Matthew Buckhalter also recently made the following trade(s):

• On Wednesday, February 18th, Matthew Buckhalter sold 13,167 shares of Aveanna Healthcare stock. The shares were sold at an average price of $7.38, for a total transaction of $97,172.46.
• On Tuesday, February 17th, Matthew Buckhalter sold 9,351 shares of Aveanna Healthcare stock. The stock was sold at an average price of $7.65, for a total value of $71,535.15.
• On Friday, January 2nd, Matthew Buckhalter sold 18,340 shares of Aveanna Healthcare stock. The stock was sold at an average price of $7.85, for a total value of $143,969.00.
• On Wednesday, December 31st, Matthew Buckhalter sold 17,289 shares of Aveanna Healthcare stock. The shares were sold at an average price of $8.18, for a total value of $141,424.02.
• On Tuesday, December 30th, Matthew Buckhalter sold 17,448 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.36, for a total value of $145,865.28.

Aveanna Healthcare Price Performance

NASDAQ:AVAH traded up $0.02 during trading hours on Thursday, hitting $7.42. The company’s stock had a trading volume of 3,877,110 shares, compared to its average volume of 938,081. Aveanna Healthcare Holdings Inc. has a 52-week low of $3.67 and a 52-week high of $10.32. The company has a debt-to-equity ratio of 140.39, a quick ratio of 1.23 and a current ratio of 1.23. The business’s 50-day moving average is $8.48 and its two-hundred day moving average is $8.44. The company has a market capitalization of $1.55 billion, a PE ratio of 20.61 and a beta of 2.06.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the stock. Raymond James Financial restated an “outperform” rating and set a $13.00 target price on shares of Aveanna Healthcare in a report on Friday, December 5th. Truist Financial boosted their price target on Aveanna Healthcare from $9.50 to $10.00 and gave the company a “hold” rating in a report on Friday, November 7th. BMO Capital Markets assumed coverage on Aveanna Healthcare in a research note on Thursday, November 13th. They set an “outperform” rating and a $11.00 price target on the stock. Weiss Ratings restated a “hold (c+)” rating on shares of Aveanna Healthcare in a report on Monday, December 29th. Finally, William Blair began coverage on Aveanna Healthcare in a research note on Monday, December 8th. They issued an “outperform” rating for the company. Five equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $11.06.

Institutional Investors Weigh In On Aveanna Healthcare

A number of institutional investors have recently added to or reduced their stakes in AVAH. AustralianSuper Pty Ltd acquired a new stake in Aveanna Healthcare during the third quarter worth about $15,743,000. Vanguard Group Inc. lifted its stake in shares of Aveanna Healthcare by 38.0% in the 4th quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock valued at $45,564,000 after purchasing an additional 1,535,351 shares in the last quarter. Millennium Management LLC grew its holdings in shares of Aveanna Healthcare by 1,007.1% during the 4th quarter. Millennium Management LLC now owns 1,114,717 shares of the company’s stock worth $9,107,000 after purchasing an additional 1,014,030 shares during the period. Nuveen LLC grew its holdings in shares of Aveanna Healthcare by 135.9% during the 4th quarter. Nuveen LLC now owns 1,571,308 shares of the company’s stock worth $12,838,000 after purchasing an additional 905,316 shares during the period. Finally, Hillsdale Investment Management Inc. acquired a new stake in Aveanna Healthcare during the 3rd quarter worth approximately $7,922,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

More Aveanna Healthcare News

Here are the key news stories impacting Aveanna Healthcare this week:

• Neutral Sentiment: Short-interest data released for Feb. 19 shows an apparent data anomaly (0 shares reported / NaN change), so there’s no clear short‑interest signal to explain price moves today. (Report notes the short‑interest ratio is effectively 0 days based on reported volume.)
• Neutral Sentiment: Market commentary explains recent intraday weakness in AVAH; see a recent write‑up for context on why the stock moved. Why AVAH is Down
• Negative Sentiment: Significant insider selling: over Feb. 17–19 multiple insiders (CEO Jeff Shaner, several executives including CFO Matthew Buckhalter and CAO Deborah Stewart, plus others such as Edwin C. Reisz and Patrick A. Cunningham) sold large blocks. Combined, these filings show roughly 740,000 shares sold across the group — about $5.4–$5.5M in proceeds — at average prices in the ~$7.20–$7.65 range. Collective, high‑profile sales of this size often weigh on near‑term investor sentiment because they increase supply and may be interpreted as insiders taking money off the table. CEO Filings Other Exec Filings

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.